101-PGC-005 for the Treatment of COVID-19

NCT05656521 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

62

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID-19

Interventions

DRUG: 101-PGC-005
DRUG: Dexamethasone

Sponsor

101 Therapeutics